| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,000 | $30 | $204K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 16,640 | $10 | $183K |
| J9312 | Injection, rituximab, 10 mg | 2,500 | $60 | $160K |
| J3262 | Injection, tocilizumab, 1 mg | 27,360 | $10 | $136.8K |
| J0897 | Injection, denosumab, 1 mg | 4,320 | $20 | $77.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 350 | $90 | $30.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 390 | $50 | $18.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 90 | $110 | $10K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 90 | $60 | $5.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 50 | $100 | $4.9K |